XML 33 R22.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

6 Months Ended

Jul. 04, 2020

Share-based Payment Arrangement [Abstract]

Stock option activity under the equity incentive plans was as follows (in thousands, except per share amounts):


	Stock Options Outstanding
	Number of Shares Subject to Stock Options	Weighted– Average Exercise Price		Aggregate Intrinsic Value ⁽¹⁾
Balance—December 31, 2019	12,871	$	3.51
Granted	—	$	—
Exercised	(857)	$	1.17
Forfeited or canceled	(87)	$	6.67
Balance—July 4, 2020	11,927	$	3.65	$	35,551

Stock options vested and expected to vest—July 4, 2020	11,927	$	3.65	$	35,551
Stock options exercisable—July 4, 2020	11,927	$	3.65	$	35,551

⁽¹⁾ The aggregate intrinsic values of stock options outstanding, exercisable, vested and expected to vest as of July 4, 2020 were calculated as the difference between the exercise price of the stock options and the fair value of the Class A common stock of $6.29 as of July 4, 2020.

Schedule of restricted stock unit activity

RSU activity under the equity incentive plans was as follows (in thousands, except per share amounts):


	RSUs Outstanding	Weighted- Average Grant Date Fair Value
Unvested balance—December 31, 2019	18,932	$	5.68
Granted	9,661	$	6.41
Vested	(5,755)	$	6.26
Forfeited or canceled	(601)	$	5.81
Unvested balance—July 4, 2020	22,237	$	5.85

Schedule of stock-based compensation expense

Total stock-based compensation expense recognized was as follows (in thousands):


	Three Months Ended						Six Months Ended
	July 4, 2020		June 29, 2019		July 4, 2020		June 29, 2019
Cost of revenue	$	2,033	$	1,521	$	4,212	$	2,951
Research and development	11,442		11,892		22,561		23,880
Sales and marketing	2,899		3,175		5,674		6,313
General and administrative	3,396		3,959		7,050		7,947
Total stock-based compensation expense	$	19,770	$	20,547	$	39,497	$	41,091